Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Statements of Operations [Abstract]    
Revenue
Operating expenses:    
Research and development, net of reimbursements 4,504,351 3,765,452
General and administrative 3,280,317 2,218,467
Depreciation expense 20,920 18,120
Total operating expenses 7,805,588 6,002,039
Loss from operations (7,805,588) (6,002,039)
Other income (expense):    
Interest expense (2,658)
Gain (loss) on change in fair value of derivative liabilities (255,995) 1,601,399
Total other income (expense) (255,995) 1,598,741
Net loss $ (8,061,583) $ (4,403,298)
Net loss per common share - basic and diluted $ (0.14) $ (0.10)
Weighted average common shares outstanding - basic and diluted 55,892,878 44,253,793